TD Cowen maintained its Hold rating and $268.00 price target on Humana stock (NYSE: HUM ) following the company's 2025 investor day presentation. According to InvestingPro data, Humana currently trades at $242.55, with analyst targets ranging from $244 to $402, suggesting potential upside. The company maintains a "GREAT" financial health score, holding more cash than debt on its balance sheet. The healthcare insurer outlined its strategy to recover Medicare Advantage margins while expanding profitability in its Medicaid and CenterWell segments.